查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1455738

全球牛初乳市场 - 2023-2030

Global Bovine Colostrum Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 210 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

2022年，全球牛初乳市场规模达到32.1亿美元，预计2030年将达到51.9亿美元，2023-2030年预测期间CAGR为6.21%。

多年来，全球牛初乳市场经历了显着的增长和转变，消费者高度采用牛初乳作为膳食补充剂，因为它是大量和微量营养素、免疫球蛋白和抗菌肽的丰富天然来源。活动，有助于促进整体健康和免疫支持。

此外，随着消费者对特色营养产品的需求不断增长，製造公司正在开发创新产品。例如，2022 年 11 月，PanTheryx 推出了 Life's First Naturals PRO 牛补充剂，这是一种专为医疗保健从业者管道配製的超强免疫支持和消化健康补充剂。

初乳和亚太地区的膳食补充剂在全球牛初乳市场中占据主导地位，因为该地区的牛奶产量和需求量都很高，这与牛初乳产品的生产保持一致，因此有助于推动全球牛初乳产品的成长。牛初乳市场。

动力学

健康和保健趋势的增加

消费者越来越多地寻求天然和营养补充剂来支持他们的整体健康。牛初乳是各种营养素和生物活性化合物的丰富来源，符合此需求，并有助于增强免疫系统和肠道健康。因此，健康和保健趋势的上升有助于推动全球牛初乳市场的发展。

此外，製造公司正在其产品组合中推出新型初乳产品。例如，2022年5月，专门生产初乳的消化和免疫支持成分公司Pantheryx推出了一款含有益生菌菌株的初乳，用于儿童和成人膳食补充剂。新的配方能力可利用初乳和动物双歧桿菌 BB-12、鼠李糖乳桿菌 LGG+、植物乳桿菌 HEAL9、副干酪乳桿菌 8700:2 和枯草芽孢桿菌 DE111 等菌株生产组合产品。

初乳腺癌盛行率增加

益生菌紊乱可导致初乳腺癌，而消费者中初乳腺癌的盛行率正在上升。例如，根据世界卫生组织 (WHO) 的报告，大肠癌是全球第三大常见癌症，约占所有癌症病例的 10%，也是全球癌症相关死亡的第二大原因。它主要影响老年人，大多数病例发生在 50 岁及以上的人群中。

此外，製造公司专注于开发各种产品以吸引更大的消费者群。例如，2022年11月，APS和凌阳宣布建立多年策略伙伴关係，共同开发新的牛初乳产品。透过此策略合作，APS 将在 sunplus 的 natrapure cbps 奶粉中首次推​​出其新的初乳碱性蛋白和免疫球蛋白配方。

乳糖不耐症盛行率上升

乳糖不耐症是一种消化系统疾病，身体无法消化乳糖，乳糖是牛奶和乳製品中发现的一种糖。根据 Medline Plus 2023 年的报告，患有乳糖不耐症的人数一直在增加。据估计，大约 65% 的人口在婴儿期后消化乳糖的能力下降。这种情况在东亚地区尤其普遍。因此，这种高流行率可能会限制较小消费者群的市场。

目录

第 1 章：方法与范围

  • 研究方法论
  • 报告的研究目的和范围

第 2 章：定义与概述

第 3 章：执行摘要

  • 自然片段
  • 按表格列出的片段
  • 按配销通路分類的片段
  • 按应用程式片段
  • 按地区分類的片段

第 4 章：动力学

  • 影响因素
    • 司机
      • 健康和保健趋势的增加
      • 初乳腺癌盛行率增加
    • 限制
      • 乳糖不耐症盛行率上升
    • 机会
    • 影响分析

第 5 章：产业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析
  • DMI 意见

第 6 章：COVID-19 分析

  • COVID-19 分析
    • 新冠疫情爆发前的情景
    • 新冠疫情期间的情景
    • 新冠疫情后的情景
  • COVID-19 期间的定价动态
  • 供需谱
  • 疫情期间政府与市场相关的倡议
  • 製造商策略倡议
  • 结论

第 7 章：本质

  • 有机的
  • 传统的

第 8 章：按形式

  • 液体
  • 粉末
  • 胶囊
  • 平板电脑

第 9 章：按配销通路

  • 大型超市/超市
  • 专卖店
  • 便利商店
  • 其他的

第 10 章：按应用

  • 膳食补充剂
  • 功能性食品
  • 动物营养
  • 化妆品
  • 婴幼儿配方奶粉
  • 药品
  • 其他的

第 11 章：按地区

  • 北美洲
    • 市场规模分析及年成长分析（%），按应用
      • 我们
      • 加拿大
      • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 俄罗斯
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 亚太其他地区
  • 中东和非洲

第 12 章：竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 13 章：公司简介

  • Colostrum BioTec GmbH
    • 公司简介
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • Zuche Pharmaceuticals.
  • Biodane Pharma A/S
  • Agati Healthcare
  • Vivesa holding sro
  • Cure Nutraceutical PVT. LTD
  • PanTheryx, Inc.
  • NOW Health Group, Inc.
  • Sterling Technology
  • Farbest Brands

第 14 章：附录

简介目录
Product Code: FB8180

Overview

Global Bovine Colostrum Market reached US$ 3.21 billion in 2022 and is expected to reach US$ 5.19 billion by 2030, growing with a CAGR of 6.21% during the forecast period 2023-2030.

The global bovine colostrum market has witnessed significant growth and transformations over the years, as consumers are highly adopting this bovine colostrum as a dietary supplement as it is a rich natural source of macro- and micro-nutrients, immunoglobulins, and peptides with anti-microbial activity, and it helps to promote general health and immune support.

In addition, as the demand for specialty nutritious products is rising among consumers, manufacturing companies are developing innovative products. For instance, in November 2022, PanTheryx launched Life's First Naturals PRO bovine supplement, an extra-strength immune support and digestive health supplement formulated for the health care practitioner channel.

The dietary supplements of colostrum and Asia-Pacific region show the dominance in global bovine colostrum market, as the milk production rate and demand are high in this region, which aligns the production of bovine colostrum products, hence, it can help in driving the global bovine colostrum market.

Dynamics

Increase in Health and Wellness Trends

Consumers are increasingly seeking natural and nutritional supplements to support their overall well-being. Bovine colostrum, being a rich source of various nutrients and bioactive compounds, aligns with this demand, and also, helps in enhancing the immune system, and gut health. Hence, the rising health and wellness trends can contribute to driving the global bovine colostrum market.

Furthermore, manufacturing companies are launching novel colostrum products in their portfolios. For instance, in May 2022, Pantheryx, a digestive and immune support ingredients company specializing in colostrum, launched a colostrum with probiotic strains for children's and adults' dietary supplements. The new formulation capability creates combination products with colostrum and strains such as Bifidobacterium animalis BB-12, Lactobacillus rhamnosus LGG+, Lactobacillus plantarum HEAL9, Lactobacillus paracasei 8700:2, and B. subtilis DE111.

Increasing Prevalences Of Colostrum Cancers

The probiotic disorder can cause colostrum cancer, and the prevalence of colostrum cancer is rising among consumers. For instance, according to a World Health Organization (WHO) report, colorectal cancer is the third most common cancer worldwide, accounting for approximately 10% of all cancer cases, and is the second leading cause of cancer-related deaths worldwide. It predominantly affects older individuals, with most cases occurring in people aged 50 and above.

In addition, manufacturing companies focus on developing a wide range of products to attract larger consumer bases. For instance, in November 2022, APS and Sunplus, announced a multi-year strategic partnership to develop new bovine colostrum products. Through the strategic partnership, APS will debut its new colostrum basic protein and immunoglobulin g formula in sunplus's natrapure cbps milk powder.

Rising Prevalence of Lactose Intolerance

Lactose intolerance is a digestive disorder where the body is unable to digest lactose, a type of sugar found in milk and dairy products. According to a report by Medline Plus in 2023, the number of people with lactose intolerance has been increasing. It is estimated that around 65% of the human population has a reduced ability to digest lactose after infancy. This condition is particularly prevalent in the East Asian region. As a result, this high prevalence rate can limit the market for smaller consumer bases.

Segment Analysis

The global bovine colostrum market is segmented based on nature, form, distribution channel, application, and region.

Increase in Adoption of Colostrum as a Dietary Supplement

The dietary supplements of colostrum have the maximum share in the global bovine colostrum market, as colostrum has high nutritional value, natural macro- and micro-nutrients, immunoglobulins, and others, the consumption of colostrum helps in improving the immune system to fight against diseases.

Furthermore, supplement-producing companies are launching innovative products. For instance, in August 2022, The Roots Brands is unveiling a one-of-a-kind blend of hydrolyzed bovine collagen and whole colostrum powder as a youth-enhancing supplement, which is Dubbed Give Me Back My Youth (GMBMY), is sourced from cows. it helps to promote type types I and Ill collagen in humans, and also boosts skin hydration, enhancing suppleness and minimizing wrinkles.

Geographical Penetration

High Milk Production

Asia-Pacific has been a dominant force in the global cow colostrum market and its significant growth. From ancient times milk and milk products have been part of the consumer's diet in this region, also the demand for cow colostrum products is rising especially in infant foods as they provide antibodies and enhance the immune health.

Furthermore, the production rate for milk is high in this region, for instance, according to the Ministry of Fisheries, Animal Husbandry & Dairying reports the milk industry has raised, since the launch of Operation Flood program. India is the largest producer of milk in the world, contributing 23% of global milk production.

Competitive Landscape

The major global players in the market include Colostrum BioTec GmbH, Zuche Pharmaceuticals., Biodane Pharma A/S, Agati Healthcare, Vivesa holding s.r.o., Cure Nutraceutical PVT. LTD, PanTheryx, Inc., NOW Health Group, Inc., Sterling Technology, and Farbest Brands

COVID-19 Impact Analysis

The outbreak of the COVID-19 pandemic in late 2019 created unprecedented challenges for industries worldwide, including the global bovine colostrum market. Many countries have imposed lockdown restrictions which have impacted the distribution channel, exports, and imports of the products.

Additionally, COVID-19 has created opportunities for manufacturers to develop innovative products with beneficial effects and to support the market, for instance, in May 2020, The Surat District Cooperative Milk Producers Union Limited developed cow colostrum powder' Sumul Immune powder, an immunity booster to protect COVID-19-positive patients, it has albumin, globulin, and Gama globulin. It is rich in vitamins A, D, E, and K and also contains 300 types of enzymes to increase gut health.

By Nature

  • Organic
  • Conventional

By Bovine

  • Liquid
  • Powder
  • Capsules
  • Tablets

By Distribution Channel

  • Hypermarkets/Supermarkets
  • Specialty stores
  • Convenience stores
  • Others

By Application

  • Dietary Supplements
  • Functional Food
  • Animal Nutrition
  • Cosmetics
  • Infant Formula
  • Pharmaceuticals
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In January 2024, Australian infant goat milk formula specialist Nuchev launches its first bovine products targeting school-going children and adults.
  • In April 2021, Kilyos Nutrition and Pantheryx are partnering for the research, development, and commercialization of bovine colostrum solutions in Brazil.

Why Purchase the Report?

  • To visualize the global bovine colostrum market segmentation based on nature, form, distribution channel, application, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of bovine colostrum market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global bovine colostrum market report would provide approximately 70 tables, 67 figures and 210 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1.Methodology and Scope

  • 1.1.Research Methodology
  • 1.2.Research Objective and Scope of the Report

2.Definition and Overview

3.Executive Summary

  • 3.1.Snippet by Nature
  • 3.2.Snippet by Form
  • 3.3.Snippet by Distribution Channel
  • 3.4.Snippet by Application
  • 3.5.Snippet by Region

4.Dynamics

  • 4.1.Impacting Factors
    • 4.1.1.Drivers
      • 4.1.1.1.Increase in Health and Wellness Trends
      • 4.1.1.2.Increasing Prevalences of Colostrum Cancers
    • 4.1.2.Restraints
      • 4.1.2.1.Rising Prevalence of Lactose Intolerance
    • 4.1.3.Opportunity
    • 4.1.4.Impact Analysis

5.Industry Analysis

  • 5.1.Porter's Five Force Analysis
  • 5.2.Supply Chain Analysis
  • 5.3.Pricing Analysis
  • 5.4.Regulatory Analysis
  • 5.5.DMI Opinion

6.COVID-19 Analysis

  • 6.1.Analysis of COVID-19
    • 6.1.1.Scenario Before COVID
    • 6.1.2.Scenario During COVID
    • 6.1.3.Scenario Post COVID
  • 6.2.Pricing Dynamics Amid COVID-19
  • 6.3.Demand-Supply Spectrum
  • 6.4.Government Initiatives Related to the Market During Pandemic
  • 6.5.Manufacturers Strategic Initiatives
  • 6.6.Conclusion

7.By Nature

  • 7.1.Introduction
    • 7.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Nature
    • 7.1.2.Market Attractiveness Index, By Nature
  • 7.2.Organic*
    • 7.2.1.Introduction
    • 7.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3.Conventional

8.By Form

  • 8.1.Introduction
    • 8.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 8.1.2.Market Attractiveness Index, By Form
  • 8.2.Liquid*
    • 8.2.1.Introduction
    • 8.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3.Powder
  • 8.4.Capsules
  • 8.5.Tablets

9.By Distribution Channel

  • 9.1.Introduction
    • 9.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.1.2.Market Attractiveness Index, By Distribution Channel
  • 9.2.Hypermarkets/Supermarkets*
    • 9.2.1.Introduction
    • 9.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3.Specialty stores
  • 9.4.Convenience stores
  • 9.5.Others

10.By Application

  • 10.1.Introduction
    • 10.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.1.2.Market Attractiveness Index, By Application
  • 10.2.Dietary Supplements*
    • 10.2.1.Introduction
    • 10.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3.Functional Food
  • 10.4.Animal Nutrition
  • 10.5.Cosmetics
  • 10.6.Infant Formula
  • 10.7.Pharmaceuticals
  • 10.8.Others

11.By Region

  • 11.1.Introduction
    • 11.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2.Market Attractiveness Index, By Region
  • 11.2.North America
    • 11.2.1.Introduction
    • 11.2.2.Key Region-Specific Dynamics
    • 11.2.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Nature
    • 11.2.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.2.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.2.6.arket Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1.U.S.
      • 11.2.7.2.Canada
      • 11.2.7.3.Mexico
  • 11.3.Europe
    • 11.3.1.Introduction
    • 11.3.2.Key Region-Specific Dynamics
    • 11.3.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Nature
    • 11.3.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.3.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.3.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1.Germany
      • 11.3.7.2.UK
      • 11.3.7.3.France
      • 11.3.7.4.Italy
      • 11.3.7.5.Russia
      • 11.3.7.6.Rest of Europe
  • 11.4.South America
    • 11.4.1.Introduction
    • 11.4.2.Key Region-Specific Dynamics
    • 11.4.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Nature
    • 11.4.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.4.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.4.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1.Brazil
      • 11.4.7.2.Argentina
      • 11.4.7.3.Rest of South America
  • 11.5.Asia-Pacific
    • 11.5.1.Introduction
    • 11.5.2.Key Region-Specific Dynamics
    • 11.5.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Nature
    • 11.5.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.5.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.5.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1.China
      • 11.5.7.2.India
      • 11.5.7.3.Japan
      • 11.5.7.4.Australia
      • 11.5.7.5.Rest of Asia-Pacific
  • 11.6.Middle East and Africa
    • 11.6.1.Introduction
    • 11.6.2.Key Region-Specific Dynamics
    • 11.6.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Nature
    • 11.6.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.6.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.6.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

12.Competitive Landscape

  • 12.1.Competitive Scenario
  • 12.2.Market Positioning/Share Analysis
  • 12.3.Mergers and Acquisitions Analysis

13.Company Profiles

  • 13.1.Colostrum BioTec GmbH*
    • 13.1.1.Company Overview
    • 13.1.2.Product Portfolio and Description
    • 13.1.3.Financial Overview
    • 13.1.4.Key Developments
  • 13.2.Zuche Pharmaceuticals.
  • 13.3.Biodane Pharma A/S
  • 13.4.Agati Healthcare
  • 13.5.Vivesa holding s.r.o.
  • 13.6.Cure Nutraceutical PVT. LTD
  • 13.7.PanTheryx, Inc.
  • 13.8.NOW Health Group, Inc.
  • 13.9.Sterling Technology
  • 13.10.Farbest Brands

LIST NOT EXHAUSTIVE

14.Appendix

  • 14.1.About Us and Services
  • 14.2.Contact Us